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 β-actin forward = 5’-TCCTCAATCTCGCTCTCGCT  
 β-actin reverse = 5’-GCCGCTGGGTTTTATAGGGC 
 GAPDH forward = 5’-CTCAAGACCTTGGGCTGGG 
 GAPDH reverse = 5’-TCGAACAGGAGGAGCAGAGA 
 Myc-u forward = 5’-GGCGTGGGGGAAAAGAAAAA  
 Myc-u reverse = 5’- CGTCCAGACCCTCGCATTAT 
 Myc-d forward = 5’-GAGGCTTGGCGGGAAAAAGA  
 Myc-d reverse = CTCTGCCTCTCGCTGGAAT 
 IIA-S forward = 5’- CTTCCCTGACAAGGCTTGAGT  
 IIA-S reverse = 5’- CAGAACTGAGCTGACGACCC 
 8 
 TBP forward = 5’-CTCAAGAGCTTCGCCCCTC 
 TBP reverse = 5’-AATGTCACTTCCGCCAGTT 
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TATA-binding protein-like protein (TLP) binds to transcription factor IIA
(TFIIA) with high affinity, although the significance of this binding is
poorly understood. In this study, we investigated the role of TFIIA in tran-
scriptional regulation of the p21Waf1/Cip1 (p21) gene. It has been shown that
TLP is indispensable for p53-activated transcription from an upstream
TATA-less promoter of the p21 gene. We found that mutant TLPs having
decreased TFIIA-binding ability exhibited weakened transcriptional activa-
tion function for the upstream promoter. Activity of the upstream pro-
moter was enhanced considerably by an increased amount of TFIIA in a
p53-dependent manner, whereas activity of the TATA-containing down-
stream promoter was enhanced only slightly. TFIIA potentiated the
upstream promoter additively with TLP. Although TFIIA is recruited to
both promoters, activity of the upstream promoter was much more depen-
dent on TFIIA. Recruitment of TFIIA and TLP to the upstream promoter
was augmented in etoposide-treated cells, in which the amount of TFIIA–
TLP complex is increased, and TFIIA-reactive TLP was required for the
recruitment of both factors. It was confirmed that etoposide-stimulated
transcription depends on TLP. We also found that TFIIA-reactive TLP
acts to decrease cell growth rate, which can be explained by interaction of
the p21 promoter with the transcription factors that we examined. The
results of the present study suggest that the upstream TATA-less promoter
of p21 needs TFIIA and TFIIA-reactive TLP for p53-dependent transcrip-
tional enhancement.
Structured digital abstract
! TLP physically interacts with TFIIA beta and TFIIA alpha by anti tag coimmunoprecipitation (View
interaction)
! TFIIA alpha/beta physically interacts with TLP by anti bait coip (View interaction)
Introduction
Transcriptional regulation of an RNA polymerase II
driven gene is governed by a particular set of gene-
specific DNA-reactive transcription regulatory factors
and their associating transcriptional cofactors. More-
over, general transcription factors such as TFIID
(transcription factor IID) and TFIIA are assembled
at a promoter region to conduct transcriptional initia-
tion [1–3], which is enhanced by gene-specific tran-
scription regulatory factors through functional
interaction.
Abbreviations
ChIP, chromatin immunoprecipitation; qPCR, quantitative PCR; siRNA, short interfering RNA; TBP, TATA-binding protein; TFIIA, transcription
factor IIA; TLP, TBP-like protein.
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TATA-binding protein (TBP) is an essential compo-
nent in TFIID that binds to the TATA-box promoter
element [2,4–6]. TBP-like protein (TLP, also called
TRF2) has been identified as one of the TBP family
proteins [7–9] and has been shown to enhance expres-
sion of TATA-less genes such as NF-1, Cyclin-G2,
TAp63 and Wee1 [10–12]. TLP is unable to bind to
the TATA-box, and a consensus TLP-binding
sequence has not been determined so far. In the Dro-
sophila PCNA gene, TLP is engaged in transcriptional
activation as a cofactor for a transcription regulatory
factor called DREF [13]. Although TLP is usually con-
centrated in the cytoplasm, it translocates to the
nucleus in a particular cell-cycle period or when acti-
vated by a genotoxin such as etoposide [12]. Hence,
TLP is thought to be involved in gene regulation
related to growth control and DNA damage response.
Recently, we have identified p21 (p21Waf1/Cip1) as one
of the TLP-target genes [14].
p21 is a CDK inhibitor and causes cell-cycle arrest
at G1 or G2 phase [15,16]. Since p21 also participates
in apoptosis, DNA repair and tumor suppression in
some cases [17], p21 is regarded as a major gene for
cell growth regulation. The amount of intracellular
p21 is regulated at the transcription level, and its
expression level is enhanced by multiple transcription
factors [18,19]. The promoter-enhancer region of p21
contains several binding sites for p53, which enhances
the promoter activity. p53, which works for genome
homeostasis, is a typical tumor suppressor and major
regulator of the p21 gene [20–22]. The human p21 gene
has two major promoters: a TATA-containing down-
stream promoter and an upstream TATA-less pro-
moter [23,24]. TFIID is recruited to the TATA-box of
the downstream promoter together with p53 upon UV
irradiation, but it does not participate in regulation of
the upstream promoter [24]. We have found that activ-
ity of the upstream promoter absolutely depends on
TLP and p53 [14], and these two factors form a com-
plex in cells [14,25].
The most attractive property of TLP is its potent
TFIIA-binding ability. TFIIA is another member of
the family of general transcription factors [3].
Although TFIIA binds to TBP to some extent in order
to potentiate TFIID-dependent promoters, it is also
used for TATA-less promoters [3,26,27]. In higher
eukaryotes, TFIIA consists of three subunits including
TFIIA a, b and c [3]. TFIIAab is encoded by a single
gene and is cleaved into individual a and b subunits
[3,28]. We have found that TLP binds more strongly
to TFIIA than to TBP [29]. Although TLP is mainly
localized in the cytoplasm, mutant TLPs with impaired
TFIIA-binding ability display a diffuse localization
pattern [29]. However, the significance of the TFIIA-
binding ability of TLP in transcriptional regulation
has remained to be clarified.
In this study, we investigated the contribution of
TLP–TFIIA interaction to p21 gene regulation, and
we found that mutant TLPs with weakened TFIIA-
binding ability exhibit decreased transcription stimula-
tion activity. Moreover, etoposide, which stimulates
p21 gene expression, facilitated binding of the
upstream promoter to TFIIA and TFIIA-reactive
TLP. One reason why TLP possesses a strong TFIIA-
binding ability may be elucidated through this study.
Results
Transcriptional activation function of mutant
TLPs for the p21 promoter
We previously constructed various kinds of mutant
TLPs [29]. Among them, N37E and R52E have weak-
ened binding ability to TFIIA, and N37E is a more
severe mutant than R52E for TFIIA binding, whereas
R55E binds to TFIIA as strongly as does wild-type
TLP. In this study, we first investigated in detail the
intracellular TFIIA-binding strength of these mutants
by co-immunoprecipitation assays. It was confirmed
that wild-type TLP and R55E exhibited significant
binding to TFIIA, whereas N37E did not bind to
TFIIA (Fig. 1). We further investigated processed and
unprocessed forms of TFIIAa/b and found that R52E
binds to the a and b subunits of TFIIA but does not
bind to uncleaved TFIIAab (Fig. 1, lane 12).
The human p21 gene produces mainly alt-a and var-
iant-1 transcripts from the upstream and downstream
promoters, respectively (Fig. 2A) [14,23]. Knockdown
Fig. 1. TFIIA-binding ability of TLP. Co-immunoprecipitation to
detect the interaction between TLP and TFIIA. Extracts of HCT116
cells into which FH-TLP (TLP) and its mutants (R55E, R52E and
N37E) had been introduced were immunoprecipitated with M2
beads (M2) and examined for indicated proteins by western blotting
using specific antibodies. Inp, input.
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of endogenous TLP resulted in decreased production
of whole p21 transcripts, mainly due to the decreased
level of alt-a transcripts (Fig. 2B). An overexpression
experiment confirmed that alt-a is specifically depen-
dent on intracellular TLP level. Next, we investigated
the transcriptional activation function of the above-
mentioned TLP mutants. R55E, which has a native
TFIIA-binding ability, considerably enhanced alt-a
production (Fig. 2C–a, lane 3), whereas R52E and
N37E exhibited almost no effect (lanes 5 and 6). R52E
and N37E showed decreased transcription stimulation
activity for the upstream promoter compared with that
of wild-type TLP and R55E (Fig. 2C). To obtain
direct evidence that TFIIA-reactive TLP potentiates
the upstream promoter, we performed a luciferase
reporter assay in mutant TLP-overexpressed cells. It
was demonstrated that R55E enhanced promoter
activity as much as wild-type TLP did, whereas R52E
and N37E had less effect on promoter activity than
did wild-type TLP (Fig. 2D). These results suggest that
TFIIA-binding ability is required for the transcription
stimulation function of TLP.
A B
C D
(a)
(a)
(b)
(b)
Fig. 2. Activation of the endogenous p21 upstream promoter by TFIIA-reactive TLP. (A) Schematic representation of the promoter region of
the human p21 gene. Transcription start sites for the upstream and downstream promoters, which produce alt-a and variant-1 transcripts,
respectively, are shown by arrows. Dotted lines (I and II) represent promoter regions included in luciferase reporter plasmids. (B) Effect of
TLP knockdown on p21 gene expression. Amounts of whole p21 transcripts (p21) and alt-a (alt-a, p21 alt-a) in HeLa cells were determined
by semi-quantitative RT-PCR (a) and RT-qPCR (b). Control siRNA is depicted as – or scr. Each mRNA level for scr (open column) is assigned
as 1.0, and relative mRNA level for siTLP (solid columns) is shown. Arrow, position of the specific signal. (C) Effects of overexpressed TLP
and its mutants on mRNA transcribed from upstream (alt-a) and downstream (variant-1) promoters. HCT116 cells into which TLP or its
mutants had been introduced were assayed for p21 transcripts by RT-PCR (a) and RT-qPCR (b) using specific primer sets. The relative
mRNA levels for TLP and N37E are displayed as ratios to the mRNA level for vec (lane 1). vec, empty vector. (D) Transcriptional activation
of the upstream promoter by mutant TLPs. HCT116 cells transfected with indicated effector plasmids together with a reporter plasmid
(p21up/GL4) carrying p21 promoter-containing DNA from !2266 to !1875 were examined by luciferase assay for transcriptional activation
function of the native and mutant TLPs.
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TFIIA sensitivity of the upstream promoter
Since TFIIA-binding ability of TLP was found to
affect the transcriptional activation function of the
upstream promoter (Fig. 2C,D), we investigated how
TFIIA works for p21 promoters. Overexpression of
TFIIAab considerably stimulated the upstream pro-
moter (Fig. 3A-a, lane 3). Since TFIIAc exhibited lit-
tle effect (Fig. 3A-a, lane 4), the concentration of
TFIIAc in cells seemed to be sufficient for the
upstream promoter. We further investigated the coop-
erative effect directed by TLP and TFIIA in transcrip-
tional regulation through co-overexpression of
TFIIAab and TLP or N37E. Although the activation
degree of TLP for the upstream promoter was 2.6-
fold, co-overexpression of both TLP and TFIIAab
yielded 4.0-fold activation (Fig. 3A-b, lanes 1–3).
However, this additive effect was relatively small (1.8-
fold) when N37E and TFIIAab were used (Fig. 3A-b,
lanes 4 and 5). A dose-responsive effect of TFIIA on
TLP-dependent promoter activation was observed
(Fig. 3A-c), suggesting physical and functional interac-
tions between TLP and TFIIA. To exclude a possibil-
ity that overexpressed TFIIA increases the amount of
TLP protein, we examined the expression level of TLP
and TFIIA and confirmed that TFIIA does not exhi-
bit a significant effect on the expression of both
endogenous and exogenous TLP (Fig. 3A-d). The
downstream promoter was potentiated only slightly by
TFIIA (Fig. 3B). Therefore it is suggested that the
upstream promoter is much more sensitive to the
A
B C
(a)
(a)
(b)
(b)
(c) (d)
Fig. 3. Activation of p21 promoter by TFIIA. The promoter activity in a reporter plasmid was examined in response to TFIIA in normal
HCT116 cells. Cells were co-transfected with TFIIA expression plasmids for TFIIAab (IIAab, IIA) and TFIIAc (IIAc), and activities of the
upstream promoter in p21up/GL4 (A) and downstream promoter in p21down/GL4 (B) were determined. (A-b) Cells were transfected with
TLP and TFIIAab or N37E and TFIIAab to investigate the additive effect of the transcription factors. (A-c) Cells were transfected with a
constant amount of TLP and an increasing amount of TFIIAab. (A-d) Expression levels of TFIIA and TLP protein were determined by
western blotting. (C) Cells were co-transfected with TFIIAab siRNA (+) or control siRNA (!) and the indicated reporter plasmids. (C-a)
Luciferase activities were determined for the upstream (up) and downstream (down) promoters; core, core region of the downstream
promoter without a TATA-box in p21core/GL4 plasmid. (C-b) Effect of TFIIA knockdown was checked by western blotting.
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concentration of TFIIA and that TFIIA-binding activ-
ity of TLP is involved in this process. Knockdown
experiments revealed that the upstream promoter is
much more dependent on TFIIA than is the down-
stream promoter (Fig. 3C–a). The effect of downregu-
lation of TFIIA by short interfering RNA (siRNA)
was evaluated by western blotting (Fig. 3C–b). We
then investigated whether TFIIA-dependent activation
of the upstream promoter occurs in p53-deficient cells.
As shown in Fig. 4A, however, TFIIA did not activate
the upstream promoter in p53-deficient cells. More-
over, the upstream promoter harboring a mutant
p53RE did not respond to TFIIA in addition to TLP
(Fig. 4B).
Recruitment of TFIIA to the upstream promoter
of the endogenous p21 gene
It has been reported that TFIIA can be recruited to
some TATA-less promoters as well as TFIID-depen-
dent TATA-containing promoters [26,27,30,31]. In this
study, we demonstrated that TFIIAab activates the
upstream promoter additively with native TLP
(Fig. 3A-b,c). We investigated whether TFIIA is asso-
ciated with p21 promoters. Although we detected chro-
matin-bound TFIIA in the upstream promoter region
(p53RE) as well as the downstream promoter region
(TATA-box) (Fig. 5B), the amount of TFIIA was lar-
ger for the downstream promoter (Fig. 5B-c), possibly
due to TFIID-assisted recruitment. We performed
TFIIA knockdown experiments to examine TFIIA
function for p21 gene regulation, and we found that
the production of alt-a mRNA was dependent on the
amount of TFIIA (Fig. 5C). The amount of p21 vari-
ant-1 (Fig. 5C) and the total amount of p21 mRNA
(data not shown) were also decreased in TFIIA-
depressed cells.
Recruitment of TFIIA and TFIIA-reactive TLP to
the upstream promoter in etoposide-treated cells
Previously, we demonstrated that p53 and TLP are
recruited to the same region of the p21 gene in etopo-
side-treated cells [14]. In this study, we confirmed that
p53 (Fig. 6A) and TLP (Fig. 6D, lanes 1 and 2) were
substantially recruited to the upstream promoters in
cells treated with etoposide, which is one of the typical
genotoxins. Figure 6B shows that large amounts of
TFIIA bind to the upstream p53RE-containing region.
Furthermore, we found that exogenous TLP but not
N37E increased the amount of upstream promoter-
bound TFIIA (Fig. 6C). These results indicate that
TFIIA-binding ability of TLP is required for recruit-
ment of TFIIA to the upstream promoter. We next
determined how many mutant TLPs are recruited to
the promoter in etoposide-treated cells. Exogenously
expressed TLP and R55E clearly bound to the p53-
responsive element (Fig. 6D, lanes 2 and 3). On the
other hand, R52E and N37E showed decreased bind-
ing signals (lanes 4 and 5) although these proteins were
substantially present in cells. A further chromatin
immunoprecipitation (ChIP) assay demonstrated that
the amount of promoter-bound wild-type TLP was sig-
nificantly increased by etoposide, whereas that of
N37E did not change and was lower than TLP, even
though amounts of N37E were higher than those of
TLP in nuclei of control and etoposide-treated cells
(Fig. 6E). Consequently, R52 and N37E, whose chro-
matin-binding results were overestimated (Fig. 6D,E),
were demonstrated to have weakened promoter-bind-
ing abilities compared with wild-type TLP. We then
examined the effect of etoposide on TLP–TFIIA inter-
action. A co-immunoprecipitation experiment revealed
that TLP and TFIIA form an intracellular complex in
etoposide-treated cells upon DNA damage (Fig. 6F).
A B
Fig. 4. p53-dependent promoter activation
by TFIIA. Promoter activation function of
TFIIA was examined in a p53-deficient
condition. (A) Experiments similar to those
for which results were shown in Fig. 3A-b,
B were performed using p53!/! HCT116
cells, and activities of upstream and
downstream promoters were determined.
(B) Cells were transfected with expression
plasmids of TLP, N37E and TFIIAab and
the activity of the upstream promoter
carrying a mutated p53 response element
(p53RE) was determined.
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The same result was obtained when exogenously
expressed FH-TFIIA was examined (data not shown).
Lastly, we investigated whether activity of the
upstream promoter is modulated by TLP in etoposide-
treated cells. TLP knockdown resulted in a decrease in
upstream promoter-driven mRNA production
(Fig. 6G, left two columns). We found that the net
quantity of knockdown-directed decreased mRNA
production in etoposide-treated cells was twice as
much as that obtained in normal cells (Fig. 6G, right
two columns). We have confirmed that etoposide
enhances transcription from the endogenous p21
upstream promoter [14,23]. These situations suggest
that etoposide-augmented promoter-recruited TLP,
perhaps together with TFIIA, works for activated
transcription from the p21 upstream promoter.
Negative regulation of cell growth by TLP and
TFIIA
In the above-described figures, we showed that TLP
and TFIIA potentiate the upstream promoter of the
p21 gene and upregulate anti-mitotic p21 protein. We
then examined how TLP and TFIIA affect the growth
profile. Knockdown experiments demonstrated that
reduction of endogenous TLP resulted in elevated pro-
liferation for both normal (Fig. 7A-a) and p53-defi-
cient cells (Fig. 7A-b). However, the rate of
proliferation acceleration caused by depression of TLP
was much higher for wild-type cells than in p53-defi-
cient cells. Moreover, overexpression of N37E exhib-
ited a slight but significant growth-inhibitory effect
compared with wild-type TLP (Fig. 7B). Knockdown
of TFIIA also resulted in acceleration of the cell pro-
liferation rate (Fig. 7C). We next examined the effects
of TLP and TFIIA on the profile of etoposide-trig-
gered cell death by knockdown experiments (Fig. 7D),
and we found that both TLP (Fig. 7D–a) and TFIIA
(Fig. 7D–b) accelerated cell death rate in a DNA-dam-
aged condition. Since TLP and TFIIA play a negative
role in cell growth and since association of the two
factors is implicated from the results shown in Fig. 7B,
these factors might modify the expression of growth-
and apoptosis-related genes including p21.
Discussion
Previously, we demonstrated that TLP, which is one of
the TBP family proteins, is involved in regulation of
the upstream promoter [14]. The most attractive prop-
erty of TLP is its stronger TFIIA-binding ability than
that of TBP [29,30], although the functional signifi-
cance of this property has not been elucidated. Bryant
et al. [31] reported that mutant TBPs with decreased
TFIIA-binding ability showed decreased transcription
activation function in vitro. In this study, we demon-
strated that Asn37 and Arg52 of TLP, which corre-
spond to TFIIA-reactive Asn189 and Arg205 of TBP,
respectively [31], are required for TFIIA binding in
human cells (Fig. 1). N37E and R52E exhibited
decreased transcriptional activation functions for the
endogenous upstream promoter, while R55E, which
A
B
C
(a)
(a)
(b)
(b)
(c)
Fig. 5. Functional association of TFIIA
with the upstream promoter. (A)
Schematic illustration around the p21
upstream region. Three regions indicated
by horizontal lines (a, control region; b,
p53RE-containing upstream promoter; c,
TATA-box-containing downstream
promoter) were assayed by ChIP. (B)
Determination of chromatin-bound TFIIA
by ChIP assay with TFIIAab-specific
antibody. (C) Effect of TFIIA knockdown
on p21 gene expression. TFIIAab was
depressed by specific siRNA, and alt-a,
variant-1 and several control RNAs were
determined by RT-PCR (a) and RT-qPCR
(b). Each mRNA level for scr (open
column) is assigned as 1.0, and relative
mRNA levels for siIIA (solid columns) are
shown.
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has substantial TFIIA-binding capacity, exhibited
native function (Fig. 2C). These mutant TLPs also
exhibited decreased transcriptional activation function
for the upstream promoter in an exogenous reporter
plasmid (Fig. 2D). Consequently, TFIIA-binding abil-
ity of TLP is thought to be required for TLP-depen-
dent transcriptional activation. Although R52E had
binding ability to processed TFIIA (Fig. 1, lane 12), it
exhibited little transcriptional function. Because unpro-
cessed TFIIA has been reported to be transcriptionally
A
D E
F G
B C
(a) (b) (c)
Fig. 6. Recruitment of TFIIA and TLP to the p21 upstream promoter upon etoposide stress. Etoposide-induced recruitment of p53 (A) and
TFIIA (B) to the upstream promoter. Normal HCT116 cells treated with etoposide were subjected to ChIP assay using specific antibodies.
ChIP enrichment was determined by qPCR. (C) Amount of chromatin-bound endogenous TFIIA was determined by ChIP using a-TFIIAab
antibody. Cells transfected with an effector plasmid (TLP or N37E) and empty vector (vec) were treated with etoposide, and chromatin-
bound TFIIA was detected for three regions as shown in Fig. 5A. (D) Binding of mutant TLPs to the upstream promoter of the endogenous
p21 gene. Cells into which FH-tagged wild-type and mutant TLP had been introduced were subjected to ChIP assay using a-FLAG M2
beads after etoposide treatment. Results are shown in the left panel. p53RE, an experimental p53RE-containing upstream promoter region;
control, negative control region. Nuclear TBP and exogenous TLP proteins were determined by western blotting. We assigned the signal
intensity of TLP (lane 2) as 1.0, and relative intensities of experimental ChIP signals are displayed as ratios to that of each TLP (right panel).
(E) Amount of chromatin-bound TLP in etoposide-treated cells. Enrichment of chromatin-bound TLP or N37E at the upstream promoter
region was determined. Cells treated with etoposide (E) or a solvent (V) were subjected to ChIP (left panel). Nuclear TBP and exogenous
TLP proteins were determined by western blotting. Relative intensity of experimental ChIP signals (E/V for each TLP protein) is also shown
(right panel). (F) Association of TFIIA and TLP in etoposide-treated cells. Cells treated with etoposide or a solvent were harvested and a
co-immunoprecipitation assay was performed. Material immunoprecipitated with a-TFIIAab antibody was detected for TLP. IP(IIA),
immunoprecipitation with a-TFIIAab. (G) Requirement of TLP for etoposide-stimulated expression of the p21 gene. HeLa cells transfected
with TLP siRNA or control siRNA were exposed to etoposide. The level of alt-a was determined by RT-qPCR. We assigned the mRNA level
of lane 1 as 1.0, and the relative mRNA level of each sample is shown.
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active [28], it is possible that binding to unprocessed
TFIIA is required for TLP function to activate p21
upstream promoter.
TFIIA activates RNA polymerase II promoters via
interaction with various transcription factors. As is gen-
erally known, TFIIA indirectly associates with the
TATA-box promoter element via TBP [1–3,6]. Li et al.
[24] showed that TFIID is recruited to the TATA-box
of the p21 downstream promoter and that p53 is associ-
ated indirectly with the TATA-box via TFIID. Indeed,
abundant chromatin-bound TFIIA was detected at the
downstream promoter (Fig. 5B). However, overexpres-
sed TFIIA enhanced the endogenous downstream pro-
moter only slightly (Fig. 3B). On the other hand, the
upstream promoter was significantly activated by
TFIIA (~3.0-fold) (Fig. 3A-a). Moreover, results shown
in Fig. 3C and maybe Fig. 5C suggest that the upstream
promoter requires a high concentration of intracellular
TFIIA for its maximal activity. It has remained a ques-
tion for a long time why TFIIA is an essential factor for
cell growth [32], despite the fact that it works just as a
cofactor. We speculate that some essential TATA-less
genes need TFIIA as well as TLP. Results shown in
Fig. 3A-b also demonstrate an additive effect between
TFIIA and TFIIA-interactive TLP but not mutant ones,
suggesting a functional interaction of these two factors
for the upstream promoter. As already stated, the
human p21 gene has two major promoters: a TATA-less
upstream promoter and a TATA-containing down-
stream promoter [23,24]. Although the mechanism by
which TFIIA exhibits different responses to the two
promoters of the p21 gene is not fully understood, the
TATA-box element seems to be one of the determi-
nants. Existence of multiple promoters of the p21 gene
might have an advantage to maximize the level of gene
expression, which is governed by different sets of tran-
scription factors, when cells are exposed to different
kinds of stimuli and stresses.
A (a)
(a)
(b)
(b)
B
C D
Fig. 7. Inhibitory effect of TLP and TFIIA on cell growth. HCT116 cells were treated with dimethylsulfoxide (A) or etoposide (D). (A) Normal
(a) and p53!/! cells (b) were transfected with TLP siRNA (siTLP) or control siRNA (scr). The cells were replated and cultured. Then cell
numbers were counted at the indicated times. (B) Growth profile of TLP-overexpressing cells. Cells transfected with an effector plasmid
expressing TLP or its mutants were replated and cell numbers were counted. (C) Growth profile of TFIIAab knockdown cells. Cells were
transfected with TFIIAab siRNA (siIIA) or control siRNA (scr), and the growth profile was analyzed. (D) Knockdown of TLP (a) or TFIIA (b) of
etoposide-treated cells. Cells transfected with siRNAs were cultured in an etoposide-containing medium and viable cells were counted at
the indicated times.
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It has been confirmed that the upstream promoter is
basically driven by p53 [23]. Activity of the upstream
promoter was almost inert in p53-deficient cells
(Fig. 4A). Moreover, TLP does not exhibit a transcrip-
tion activation function for the upstream promoter in
p53-null cells. We found that the upstream promoter is
upregulated by TFIIA and is dependent on TFIIA in
addition to p53 and TLP (Figs 3 and 4). The results
shown in Figs 5 and 6 demonstrate that these three
transcription factors are recruited to the upstream pro-
moter, and etoposide, which stimulates p21 gene
expression, increased this recruitment. Drosophila TLP
works as a cofactor for DREF transcription factor of
the PCNA gene [13]. Moreover, TFIIA can work as a
co-activator of several activators [33–36] and binds to
p53 [37]. We have observed intracellular binding of
TLP and TFIIA [29]. Furthermore, we showed interac-
tion between TLP and p53 [25]. We therefore speculate
that TLP can form a triple complex with TFIIA and
p53, and TLP and TFIIA coordinately function as a
binary co-activator complex for p53 on the p21
upstream promoter. The fact that the native, but not
N37E, TLP stimulates the upstream promoter addi-
tively with TFIIA (Fig. 3A-b) supports this hypothesis.
In addition to p21, TLP and p53 are widely
involved in growth repression and apoptosis of cells.
The present study revealed that TFIIA is also associ-
ated with the function of TLP. The results presented
in Fig. 7A show that TLP-mediated growth repression
is dependent on p53. Since TLP with decreased TFIIA
reactivity exhibited a weaker growth-inhibitory effect
(Fig. 7B), some parts of TLP-mediated growth repres-
sion can be governed by at least TLP- and TFIIA-
dependent transcription from the upstream promoter
of the anti-mitotic p21 gene. Furthermore, we observed
that TLP and TFIIA are also involved in etoposide-
mediated cell death (Fig. 7D). We believe that TLP
and TFIIA contribute to this phenomenon through
interaction with the p21 upstream promoter.
Materials and methods
Cell culture, drug treatment and DNA
transfection
Human HCT116 cells (wild-type and p53-deficient mutant
cells) [27] and HeLa cells were maintained in Dulbecco’s
modified MEM with high glucose and low glucose respec-
tively (Sigma-Aldrich, St. Louis, MO USA) at 37 °C in the
presence of 10% fetal bovine serum. Cell numbers were
counted by the trypan blue dye-exclusion method with a
hematocytometer. Etoposide dissolved in dimethylsulfoxide
was added to the medium to 30–50 lM. Transfection of
nucleic acids was performed by using Lipofectamine and
Plus Reagent (Invitrogen, Carlsbad CA, USA).
Expression plasmids for mammalian cells
pCIneo-FH-TLP, which is an expression plasmid of flag/oli-
gohistidine (FH) tagged mouse TLP, was described previ-
ously [14]. Mouse and human TLPs have an identical amino
acid sequence. Plasmids for mutant TLPs (R55E, R52E and
N37E) were described previously [29]. TFIIA expression
plasmids, pCIneo-FH-TFIIAab and pCIneo-FH-TFIIAc,
have an open reading frame of human TFIIAab and
TFIIAc with an FH-tag at their amino termini.
Reporter plasmids for luciferase assay
pGL4.10 vector (Promega, Madison WI, USA) was used
for construction of luciferase reporter plasmids. A reporter
plasmid (designated p21up/GL4) containing a human p21
promoter region encompassing from !2266 to !1875 was
described previously [14]. The +1 position represents the
transcription start site of the downstream promoter. In this
study, we constructed two new luciferase reporter plasmids,
p21down/GL4 and p21core/GL4, that contain a down-
stream promoter region from !168 to +66 and a short
DNA stretch from !5 to +66 of the p21 downstream pro-
moter, respectively. These constructs were generated by a
PCR-based strategy using a reporter plasmid encompassing
from !2677 to +66, which has been named p21luc1 as pre-
viously described [14]. Primer sets to amplify DNA frag-
ments from !168 to +66 and from !5 to +66 sequences
were as follows: !168 to +66 forward, 50-
CTCGAGGGCCTGCTGGAACTCGGCCAG; !5 to +66
forward, 50-CTCGAGGCGCCAGCTGAGGTGTGAGCA;
and common reverse, 50-AGATCTCGGCGAATCCGCGC
CCAGCT.
RNA interference
siRNAs were prepared by a Silencer siRNA Construction
Kit (Ambion, Carlsbad, CA, USA). Sequences for target
human TFIIAab were 50-GATGGGCAGGTGGAAGAAG
(sense) and 50-CTTCTTCCACCTGCCCATC (antisense).
The sequence for human TLP was described previously
[14]. A scrambled sequence of a part of TFIIAab was used
as a control siRNA. Cells were transfected with 50–100 nM
of siRNA and cultured for an appropriate period.
PCR
Total cellular RNAs were prepared using an RNeasy Mini
Kit (Qiagen, Chatsworth, CA, USA), and RT-PCR was
performed as described previously [38]. Amplified products
were analyzed by agarose gel electrophoresis. Quantitative
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determination of the PCR products (qPCR) was performed
using a Thunderbird qPCR Mix (Toyobo, Osaka, Japan)
and 7300 Real Time PCR System (Applied Biosystems,
Foster City, CA, USA). All reactions were performed in
triplicate. Primer sets to detect p21 transcripts were as
follows: total p21 forward, 50-GACACCACTGGAGGG
TGACT; reverse, 50-CCCTAGGCTGTGCTCACTTC; alt-
a forward, 50-GGTGGCTATTTTGTCCTTGG; reverse, 50-AC
AGGTCCACATGGTCTTCC; variant-1 forward, 50-CTGCC
GAAGTCAGTTCCTTG; reverse, common to alt-a reverse.
Luciferase assay
Cells were inoculated into a 24-well plate (8 9 104
cells!well"1). Twenty-four hours later, cells were transfected
with the indicated amount of a reporter plasmid and an
effector plasmid and cultured for 24 h. Total amounts of
transfected DNA were adjusted with pRL-TK (Promega).
Cells were disrupted with a Passive Lysis Buffer (Promega).
Luciferase activity in lysates was determined by a Dual
Luciferase Reporter Assay System (Promega).
Immunoprecipitation of intracellular proteins
Cell extracts were prepared as previously described [29]. Five
hundred micrograms of the extract was used for immunopre-
cipitation. Endogenous proteins in extracts were mixed with
a specific antibody and precipitated with protein G-Sepha-
rose 4 Fast Flow (GE Healthcare Bioscience, Piscataway,
NJ, USA). FH-proteins in extracts were precipitated by anti-
Flag M2 Affinity Gel (Sigma-Aldrich). Normal rabbit IgG
(Santa Cruz, Santa Cruz, CA, USA) and IgG-Sepharose 6
Fast Flow (GE Healthcare Bioscience) were used as control
antibodies. Bound proteins were eluted and analyzed by wes-
tern blotting as described before [29].
Western blotting
Proteins were separated by SDS/PAGE, transferred to an
Immobilon-P poly(vinylidene difluoride) membrane (Milli-
pore, Billerica, MA, USA) and detected by an ECL Prime
(GE Healthcare Bioscience) as previously described [29] by
using specific antibodies and appropriate horseradish-per-
oxidase-conjugated secondary antibodies including anti(a)-
rabbit IgG and a-mouse IgG. As primary antibodies, we
used a-p53 antibody (Santa Cruz), a-b-actin antibody
(Sigma-Aldrich) and antigen-purified a-TLP antibody and
TFIIAab antibody as described previously [29].
Chromatin immunoprecipitation (ChIP)
Cells transfected with plasmids were treated with 50 lM eto-
poside for an appropriate time. After fixation of cells, ChIP
assay was performed as described previously [14]. Endoge-
nous and exogenous FH-proteins were precipitated with a
specific antibody and Protein G-Sepharose 4 Fast Flow (GE
Healthcare Bioscience) and a-Flag M2 Affinity Gel (Sigma-
Aldrich), respectively. Immunoprecipitated DNAs and con-
trol input DNAs were analyzed by semi-quantitative PCR or
qPCR using p21 promoter-specific primer sets. Primer sets
for ChIP analysis were as follows: p53RE forward, 50-CAC
CTTTCACCATTCCCCTA; reverse, 50-GCAGCCCAAGG
ACAAAATAG; TATA-box forward, 50-TGCTGGAAC
TCGGCCAGGCTCAGCTG; reverse, 50-CCAGCTCCG
GCTCCACAAGGAACTG; control forward, 50-TGGTAG
GCCTCTCCAAGGTA; reverse, 50-ACACATGTGACTTG
GGGTGA.
Statistical analysis
Data in this study are shown as mean # standard error of
the mean obtained from at least three independent experi-
ments. Statistical significance of quantitative data was
determined using Bonferroni’s method with R CONSOLE (ver.
3.0.3). The number of experiments used for statistical
analysis was at least three (n = 3). P < 0.05 was considered
to be statistically significant. Statistical significance of dif-
ferences between samples is shown in the figures with aster-
isks: *P < 0.05; **P < 0.01; ***P < 0.001.
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ABSTRACT
TBP-TFIIA interaction is involved in the potentiation
of TATA box-driven promoters. TFIIA activates tran-
scription through stabilization of TATA box-bound
TBP. The precursor of TFIIA is subjected to Taspase1-
directed processing to generate ! and " subunits.
Although this processing has been assumed to be re-
quired for the promoter activation function of TFIIA,
little is known about how the processing is regu-
lated. In this study, we found that TBP-like protein
(TLP), which has the highest affinity to TFIIA among
known proteins, affects Taspase1-driven processing
of TFIIA. TLP interfered with TFIIA processing in vivo
and in vitro, and direct binding of TLP to TFIIA was
essential for inhibition of the processing. We also
showed that TATA box promoters are specifically po-
tentiated by processed TFIIA. Processed TFIIA, but
not unprocessed TFIIA, associated with the TATA
box. In a TLP-knocked-down condition, not only the
amounts of TATA box-bound TFIIA but also those of
chromatin-bound TBP were significantly increased,
resulting in the stimulation of TATA box-mediated
gene expression. Consequently, we suggest that TLP
works as a negative regulator of the TFIIA processing
and represses TFIIA-governed and TATA-dependent
gene expression through preventing TFIIA matura-
tion.
INTRODUCTION
The assembly of the transcription initiation complex on a
promoter region is a critical step in gene expression. The
TATA box is a promoter-proximal regulatory element that
is responsible for high transcription ef!ciency ofRNApoly-
merase II (polII)-dependent genes (1,2). It is known that
over 20% of polII-driven promoters have a TATA box (3).
Recruitment of general transcription factors (GTFs) de-
termines the activity of TATA box-containing promoters
(TATA promoters). TATA-binding protein (TBP), which is
amain component of transcription factor IID (TFIID), rec-
ognizes and directly binds to the TATA box, and it recruits
other GTFs to the promoter-proximal region (2,4–6). Tran-
scription factor IIA (TFIIA) is another GTF and is known
to be a binding partner of TBP (7–9). TFIIA enhances the
transcription activity of TATA promoters through stabi-
lization of binding of TBP to the TATA box. TFIIA di-
rectly binds to TBP and constitutes the core of the preiniti-
ation complex with TFIIB. In addition, TFIIA has been re-
ported to have an activator-like function (10,11), implying
that transcription is regulated by TFIIA via various mecha-
nisms. Otherwise, TFIIA is a biologically signi!cant protein
since it is essential for cell growth (12). However, compared
with other GTFs, TFIIA has not been deeply investigated
from mechanistic point of view in gene expression.
TFIIA consists of !, " and # subunits (9). TFIIA! and
" are encoded by single gene called TFIIA-L, which is re-
ferred to as TOA1 in budding yeast. The TFIIA!" precur-
sor is processed by Taspase1 at the QVDG site (13), and
processed TFIIA! and " assemble into a holo-TFIIA com-
plex together with TFIIA# (!/" + # ). The holo-TFIIA
complex has been thought to be a transcriptionally func-
tional form of TFIIA. In the process of spermatogenesis,
the TFIIA!" precursor is processed by Taspase1 alongwith
development, and holo-TFIIA potentiates the expression of
spermatogenic genes (14). In cultured HeLa cells, most of
the TFIIA proteins exist as processed forms. On the other
hand, it has been reported that the unprocessed TFIIA!"
precursor itself also has a transcription activation function.
An abnormality in the development of a TFIIA-de!cient
Xenopus embryo was rescued by the introduction of un-
cleavable TFIIA (13). It has also been reported that, unpro-
cessed TFIIA!" in P19 embryonic carcinoma cells forms
a complex with TBP and TFIIA# , which is referred to as
TAC (TBP-TFIIA-containing) complex (15,16). Those re-
ports suggest that processed and unprocessed TFIIAs each
have a speci!c role in cell growth and development. The
function of processed and unprocessed TFIIAs has there-
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fore been studied in speci!c biological conditions like em-
bryonic development. Moreover, the mechanistic investiga-
tion for each form of TFIIA has been performed just by
in vitro analyses. Eventually, the intrinsic and general sig-
ni!cance of the processing in transcriptional regulation is
remained to be elucidated. Therefore, studies in functional
differences between processed and unprocessed TFIIA and
the regulatory mechanism of TFIIA processing are to be
carried out by using commonly used cells such as HeLa
cells.
TBP-like protein (TLP) was identi!ed as one of the
TFIIA-binding proteins with the highest af!nity (17,18).
TLP, also known as TRF2, is a member of the TBP-family
proteins (19–22). Amino acids of TBP for binding to TFIIA
andTFIIB are conserved in TLP, even thoughTLPdoes not
bind stably to the TATA box sequence. It has been reported
that the af!nity of TLP to TFIIA is one order higher than
that of TBP (18). We previously found that interaction be-
tween TLP and TFIIA is required for activation of TATA-
less promoters (23–25). TLP and TFIIA regulate cell prolif-
eration through activation of the upstream promoter of the
p21 gene in a p53-dependent manner. A recent study has
also shown that TLP is engaged in potentiation of several
types of TATA-less promoters of Drosophila (26,27). Fur-
thermore, in an in vitro assay system, TLP inhibits TATA
box-driven transcription by competing with TBP for TFIIA
association (28). However, the in vivo role of TLP in TATA
box promoters remains unclear.
In this study, we examined the effect of TLP-TFIIA inter-
action on TATA promoters and found that TLP represses
TATA box-driven gene expression in vivo. We propose as
a new mechanism that TLP represses promoter activity
by preventing Taspase1-mediated processing of TFIIA. We
also found that the TFIIA!" itself is not involved in TATA
box-mediated transcription activation and the processing of
the TFIIA!" precursor by Taspase1 is essential for full po-
tentiation of TATA box promoters in cultured human cells.
The role of TLP-TFIIA interaction is thought to be a criti-
cal determinant for expression of TATA box genes.
MATERIALS AND METHODS
Cell culture, transfection and drug treatment
Human HCT116 cells and HeLa cells were maintained
in Dulbecco’s modi!ed MEM with high and low concen-
tration of glucose, respectively (Sigma-Aldrich) at 37◦C
in the presence of 10% fetal calf serum. Knockdown ex-
periments were performed as described previously (25).
Lipofectamin2000 reagent (Invitrogen) was used for trans-
fection of plasmids and siRNA. Cycloheximide (CHX)
and MG132 dissolved in dimethyl sulfoxide (DMSO) were
added to the media for some experiments.
Plasmids
Mammalian expression plasmids: expression plasmids
for "ag/oligohistidine-tagged (FH)-TLP, FH-N37E, FH-
TFIIA-L, FH-TFIIA-S and FH-MyoD were described
previously (25,29). pCIneo-FH-TBP has an open read-
ing frame of human TBP with an FH-tag at each of its
amino termini. DGAA mutant of TFIIA-L was generated
by a polymerase chain reaction (PCR)-based mutagenesis
method from pCIneo-FH-TFIIA-L. Amino acids of the
274th aspartic acid and 275th glycinewere substituted by ala-
nine in the DGAA mutant.
Bacterial expression plasmids: open reading frames of
TBP, Taspase1, TFIIAαβ and TFIIAγ were subcloned into
a pET-3a vector (Novagen). An FH-tag was added to each
of the amino terminal ends of the open reading frames of
TBP and Taspase1, and oligohistidine (His)-tag was linked
to that of TFIIAγ .
Reporter plasmids for luciferase assay: a pGL4.10 vec-
tor was used for construction of reporter plasmids. Pro-
moter regions of human p21 were ampli!ed from human
genomicDNAand cloned into a pGL4 vector by a standard
PCR-based method. p21-168/GL4, p21-65/GL4 and p21-
5/GL4 harbor distinct length of the p21 promoter as shown
in Figure 2A(a). In the !gure, +1 represents the transcrip-
tion start site of a promoter gene. GAPDHWT/GL4, which
carryies a promoter region from −145 to +52 of the hu-
man GAPDH gene, was also generated as described above.
GAPDHmutTATA/GL4, which is a mutant construct of
GAPDHWT/GL4, has a disrupted TATA box sequence.
PCR
Preparation of total cellular RNAs and reverse tran-
scription PCR (RT-PCR) and quantitative PCR (qPCR)
were performed as previously described (25,30). Semi-
quantitative PCR was performed using Paq5000 DNA
polymerase, and ampli!ed products were analyzed by 2%
agarose gel electrophoresis. All reactions were performed in
triplicate. Primer sets to detect transcripts were as follows:
"-actin forward, 5′-ACTGGGACGACATGGAGAAAA;
reverse, 5′-GATAGCACAGCCTGGATAGCAA;
GAPDH forward, 5′-GTCAAGGCTGAGAACGGGAA;
reverse, 5′-AAATGAGCCCCAGCCTTCTC; c-Myc
forward, 5′-CATCAGCACAACTACGCAGC; reverse,
5′-GCTGGTGCATTTTCGGTTGT; !-tubulin for-
ward, 5′-CTGGCTTCACCTCACTCCTG; reverse,
5′-GAAGGCACAGTCTGAGTGCT; BRCA1 for-
ward, 5′-GGTGGTACATGCACAGTTGC; reverse,
5′-ACTCTGGGGCTCTGTCTTCA; TLP forward,
5′-GGAAGATTGCTTTGGAAGGAGC; reverse,
5′-CCTGAGGACCAAATTGTAGCTG; INK4a for-
ward, 5′-GAATAGTTACGGTCGGAGGC; reverse,
5′-GTACCGTGCGACATCGCGAT; LMNA for-
ward, 5′-TCGCATCACCGAGTCTGAAG; reverse,
5′-ACTGAGTCAAGGGTCTTGCG; TBP forward,
5′-CTGGCCCATAGTGATCTTTGC; reverse, 5′-
TCAATTCCTTGGGTTATCTTCACA; TFIIA-S for-
ward, 5′-TTTGGGAAACAGTCTTCAGGA; reverse,
5′-CCATCACAGGCTACAATTTTCA; 14-3-3# for-
ward, 5′-AGAGCGAAACCTGCTCTCAG; reverse,
5′-CTCCTTGATGAGGTGGCTGT; GADD45 for-
ward, 5′-ACGAGGACGACGACAGAGAT; reverse,
5′-GCAGGATCCTTCCATTGAGA; p21alt-a for-
ward, 5′-CTGTTTTCAGGCGCCATGTC; reverse,
5′-GGTGGCTATTTTGTCCTTGG
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Figure 1. Negative function of TLP in endogenous gene expression. (A) Effect of TLP knockdown on endogenous gene expression of human cells. HeLa
cells were transfected with TLP siRNA (siTLP) and control siRNA (scr), and amounts of mRNAs were determined by qRT-PCR. Relative amount of
mRNA with siTLP (solid columns) to that with scr (open columns) for each of the genes is shown. Knockdown ef!ciency of TLP was checked by Western
blotting (left panel). (B) Effect of exogenous expression of TLP on endogenous gene expression. HeLa cells were transfected with TLP siRNA together with
a TLP expression plasmid. TLP mRNA was determined by semi-qRT-PCR (a). mRNAs of GAPDH, c-Myc and TFIIA-S were determined by qRT-PCR
(b–d). (C) Amounts of chromatin-bound TFIIA. TLP-knocked-down HeLa cells were subjected to a ChIP assay using a TFIIA!"-speci!c antibody. ChIP
enrichment was determined by qPCR. IgG and IIA: IgG- and TFIIA-speci!c immnoprecipitates, respectively. Myc-u and Myc-d indicate upstream and
downstream promoters of the c-Myc gene, respectively. p21FUR indicates the far-upstream region (-7018 to -6833) of the p21 promoter used as a negative
control.
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Figure 2. TLP-dependent repression of TATApromoters. (A) Luciferase reporter assay for TATA-containing human p21 promoters. HeLa cells transfected
with TLP siRNA together with the indicated p21 promoter reporter were examined for relative luciferase activity. (a) Schematic representation of the
promoter regions of the human p21 gene inserted in p21-168/GL4, p21-65/GL4 and p21-5/GL4. Open arrowheads show the TATA box sequence. (b)
Relative promoter activity was determined. (B) Luciferase reporter assay for TATA-containing human GAPDH promoter. Relative luciferase activity of
theGAPDH promoter in TLP-knocked-downHeLa cells and the ratios were determined as described above.WT: wild-type TATA box-harboringGAPDH
promoter. mutTATA: consensus TATA box sequence of the GAPDH promoter (TATAAAT) was mutated to gcggttg. (C) Effect of overexpressed TLP on
GAPDH promoter activity. Wild-type TLP and its mutants R55E, R52E and N37E were introduced into HeLa cells together with a GAPDH promoter-
containing reporter plasmid, and relative luciferase activity was determined. (D) Effect of co-expression of TLP and TFIIA on the p21 promoter. HCT116
cells were transfected with TFIIA expression plasmids together with TLP (b) and N37E (c) expression plasmids, and the ratios of luciferase activity of
p21-168/GL4 (vec = 1.0) are shown.
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Luciferase reporter assay
A luciferase assay was performed as previously described
(25). In a TLP-knocked-downed condition, siRNA for TLP
was introduced into cells 36 h before transfection of re-
porter and effector plasmids. Cells were transfected with
the indicated amounts of reporter plasmids and cultured
for 12–24 h. Then the cells were disrupted with a Passive
Lysis Buffer (Promega). Luciferase activity in lysates was
determined by a Dual Luciferase Reporter Assay System
(Promega). Amounts of transfected DNA were standard-
ized with a control thymidine kinase promoter (Promega).
In a single luciferase assay, luciferase activity was normal-
ized with protein concentration of lysates determined by the
BCA method.
Immunoprecipitation
Cell extracts were prepared as previously described (18).
Three hundred micrograms of the extract was used for im-
munoprecipitation. Extracts were mixed with a speci!c an-
tibody and precipitated with protein G-Sepharose 4 Fast
Flow (GE Healthcare Bioscience). Exogenous FH-tagged
proteins in extracts were precipitated with anti-Flag M2
Af!nity Gel (Sigma-Aldrich). Normal rabbit IgG (Santa
Cruz) and IgG-Sepharose 6 Fast Flow (GEHealthcare Bio-
science) were used as control antibodies. Bound proteins
were eluted and detected by Western blotting as described
before (18).
Western blotting
Proteins were separated by SDS-PAGE, transferred to an
Immobilon-P PVDF membrane (Millipore), and detected
by an ImmnoStar Zeta (Wako) by using speci!c anti-
bodies and appropriate horseradish peroxidase-conjugated
secondary antibodies including anti (!)-rabbit IgG and
!-mouse IgG. The primary antibodies used included !-
p53 antibody (Santa Cruz), !-"-actin antibody (Sigma-
Aldrich), !-GAPDH antibody (Santa Cruz), !-!-tubulin
antibody (Santa Cruz), !-p21 antibody (Santa Cruz) and
!-FLAG M5 antibody (Sigma-Aldrich). Anti-TLP, !-
TFIIA!", !-TFIIA# , !-TBP and !-TFIIB antibodies were
used as antigen-puri!ed antibodies.
Chromatin immunoprecipitation (ChIP)
ChIP was performed by a previously described method
(23). Brie"y, cells were cross-linked with formaldehyde, fol-
lowed by cell lysis and DNA-fragmentation by micrococcal
nuclease. Endogenous proteins and exogenous FH-proteins
were precipitated with a speci!c antibody using Protein
G-Sepharose 4 Fast Flow (GE Healthcare Bioscience)
and !-Flag M2 Af!nity Gel (Sigma-Aldrich), respectively.
Antigen-puri!ed !-TFIIA!" antibody and commercial
!-TBP antibody (Santa Cruz) were used for ChIP analyses.
Immnoprecipitated DNAs were puri!ed and analyzed
by qPCR. Primer sets for ChIP analysis were as follows:
"-actin forward, 5′-TCCTCAATCTCGCTCTCGCT; re-
verse, 5′-GCCGCTGGGTTTTATAGGGC; GAPDH
forward, 5′-CTCAAGACCTTGGGCTGGG; re-
verse, 5′-TCGAACAGGAGGAGCAGAGA; Myc-u
forward, 5′-GGCGTGGGGGAAAAGAAAAA; re-
verse, 5′- CGTCCAGACCCTCGCATTAT; Myc-d
forward, 5′-GAGGCTTGGCGGGAAAAAGA; re-
verse, CTCTGCCTCTCGCTGGAAT; IIA-S for-
ward, 5′- CTTCCCTGACAAGGCTTGAGT; re-
verse, 5′- CAGAACTGAGCTGACGACCC; TBP
forward, 5′-CTCAAGAGCTTCGCCCCTC; reverse,
5′-AATGTCACTTCCGCCAGTT.
Electrophoretic mobility shift assay (EMSA)
EMSA was conducted with puri!ed recombinant proteins.
Double-stranded DNA carrying a GAPDH TATA box se-
quence (sense: CGGTTTCTATAAATTGAGCC) was la-
beled with 32P-# -ATP as previously described (23), and 80
000 cpm of the DNA probe was used for each EMSA re-
action. Fifty nanograms of TBP was mixed with 40 ng of
TFIIA# and 40 ng of processed or unprocessed TFIIA!" in
EMSA buffer (20 mMHepes-KOH [pH 7.9], 5 mMMgCl2,
100 mM KCl, 0.2 mM EDTA, 5 mM dithiothreitol, 10%
glycerol) and incubated at 37◦C for 30 min to form TBP-
TFIIA complex. Labeled probeDNAwas then added to the
mixture and incubated at 30◦C for 45 min to form protein-
DNA complex. Protein-DNA complexes were separated by
4% native PAGE and detected by autoradiography. If nec-
essary, unlabeled probe DNA was added to the binding re-
action as a competitor.
Puri!cation of bacterially expressed proteins
FH-TBP, FH-Taspase1, TFIIA!" and His-TFIIA# were
transformed into BL21 (DE3) E. coli., and the recombinant
proteins were induced by isopropyl-1-thio-"-D-galactoside.
Cells were lysedwith lysis buffer (500mMNaCl, 10mM im-
idazole, 1% Triton X-100, 10% glycerol, protease inhibitor
mix [PImix]). Proteins were puri!ed from lysates using anti-
Flag M2 Af!nity Gel or Ni-NTA Agarose (QIAGEN). Al-
though TFIIA!" has no appending tags, it binds to Ni-
NTA due to an oligohistidine moiety in the central region
of the polypeptide. Af!nity carriers were washed three times
with lysis buffer, andM2 andNi-NTA-bound proteins were
eluted with FLAG peptide and imidazole, respectively.
For preparation of processed TFIIA! and " subunits, 1
$g of the TFIIA!" precursor was mixed withM2 Agarose-
bound FH-Taspase1 in a reaction buffer (20 mM Hepes-
KOH [pH 7.9], 5mMMgCl2, 100mMKCl, 0.2mMEDTA,
5 mM dithiothreitol, 10% glycerol) and incubated at 37◦C
for 1 h. M2 Agarose-bound FH-Taspase1 was eliminated
from the TFIIA solution by centrifugation centrifuge. Pro-
cessing of the TFIIA!" precursor was checked by SDS-
PAGE and silver staining.
Cell fractionation
A method described by Xie et al. (31) was used for prepa-
ration of chromatin-free and chromatin-bound fractions.
Cells were lysed with NETN100 buffer (100 mM NaCl, 1
mM EDTA, 0.5% NP-40, 20mM Tris-HCl [pH 7.5]), and
the supernatant fraction was collected as the chromatin-
free fraction. Chromatin pellets were washed twice with
NETN100 buffer. The pellets were then suspended in
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NETN420 buffer (420 mM NaCl, 1 mM EDTA, 0.5% NP-
40, 20mM Tris-HCl [pH 7.5]) and the supernatant material
was collected as the chromatin-bound fraction.
Statistical analysis
Data obtained in this study are shown as means± standard
error of means from at least three independent experiments.
Statistical signi!cance of quantitative data was determined
by Bonferroni’s method with R Console (ver.3.0.3). P <
0.05 was regarded as statistically signi!cant. Statistical sig-
ni!cance of differences between samples is shown in !gures
with asterisks such as *; P < 0.05, **; P < 0.01 and ***; P
< 0.001.
RESULTS
Repression of TATA box genes by TLP
A subset of TATA-less promoters including NF1, TAp63
and p21 is potentiated by TLP through its recruitment to
a promoter region (23–25,32,33). On the other hand, TLP
is reported to have neither af!nity to TATA box DNA nor
a function for activation of TATA box-containing promot-
ers (TATA promoters) (22). Indeed, chromatin-bound TLP
was not detected in TATApromoters in our previous works.
Rather, TLPwas shown by in vitro analyses to repress TATA
promoters (28,32). In this study, to elucidate the in vivo func-
tion of TLP in a TATA box, we !rst performed knock-
down experiments to investigate effect of TLP on expression
of endogenous genes. Knockdown of endogenous TLP in-
creased mRNAs of TATA genes (β-actin, GAPDH, c-Myc,
α-tubulin and BRCA1) (Figure 1A). In contrast, expression
of TATA-less genes (INK4a, LMNA, TBP, TFIIA-S, 14-
3-3σ , GADD45 and p21alt-a) was not increased by TLP
knockdown (Figure 1A). Rather, expression of GADD45
and p21alt-a was decreased by TLP knockdown, suggest-
ing that TLP potentiates a subset of TATA-less promoters.
Additionally, expression of GAPDH and c-Myc was sup-
pressed when TLP expression was recovered by introduc-
tion of a TLP expression plasmid (Figure 1B). These re-
sults demonstrate that TLP affects the expression of TATA
genes.
We next examined the effect of TLP on the in vivo
promoter-associating capacity of TFIIA. ChIP results con-
!rmed that TFIIA was enriched in TATA promoters (Fig-
ure 1C). We found that TLP knockdown increased the
amount of TATAbox-boundTFIIA (Figure 1C). Consider-
able amounts of promoter-associating TFIIA were detected
in TATA box-carrying GAPDH, β-actin and c-Myc pro-
moters under a TLP-knocked-down condition (Figure 1C,
lanes 1–8). The human c-Myc gene has two TATA promot-
ers (34), and the amount of promoter-bound TFIIA was in-
creased for both TATA elements (Figure 1C, lanes 5–8).
We further examined whether the TATA box sequence
is critical for TLP-mediated repression of promoters. We
performed a luciferase reporter assay using p21 (CDKN1A)
and GAPDH promoters. In a TLP-knocked-down con-
dition, the TATA box-harboring p21 promoter exhibited
higher activity than that of the control one (Figure 2A).
Similarly, the GAPDH promoter was signi!cantly elevated
by TLP knockdown, while mutation of a canonical TATA
sequence to a non-TATA sequence abolished the TLP sen-
sitivity (Figure 2B), indicating that TLP affects promoter
activity via the TATA box sequence. Consistent with the re-
sults described above, TLP overexpression donwregulated
the activities of TATA-containingGAPDH (Figure 2C) and
p21 promoters (data not shown). Additionally, we exam-
ined three TLP mutants R55E, R52E and N37E. While
R55E has normal TFIIA binding ability, R52E and N37E
have been shown to be defective just in TFIIA binding abil-
ity (18). TFIIA-reactive R55E exhibited a repression effect
on TATA-promoters as the wild-type TLP did (Figure 2C,
lanes 2 and 3). Notably, R52E and N37E, which do not
interact with TFIIA, did not affect those promoter activ-
ities (Figure 2C, lanes 4 and 5), implying that TFIIA re-
activity of TLP is required for repression of the TATA pro-
moter by TLP.We then examined a synergistic effect of TLP
and TFIIA on the TATA promoter. Exogenously expressed
TFIIA potentiated the TATA promoter of p21 (Figure 2D,
panel a), and that promoter activation was suppressed by
TLP overexpression (panel b), while the repression was not
restored byN37E (panel c). These results suggested that, al-
though endogenous TLP does not associate with the TATA
promoter, it represses TATA-containing genes through in-
hibition of TFIIA activity needed for TATA promoters.
Inhibition of TFIIA maturation by TLP
We next focused on the mechanism of TLP-mediated re-
pression of TFIIA activity. Since the TFIIA!" precursor
is processed into mature ! and " subunits by Taspase1 (13),
the processing is a key step for intracellular TFIIA activ-
ity. To investigate the effects of TLP on TFIIA processing,
we performed overexpression and knockdown experiments.
The TFIIA!" precursor has been reported to be rapidly
processed into matured subunits in cells (35). Indeed, we
found that the half-life of intracellular TFIIA!" was less
than 30 min. However, the amount of TFIIA!" signi!-
cantly increased in a TLP-overexpressed condition, and the
half-life was prolonged to over 1 h (Figure 3A, lanes 5–8).
Stabilization of the TFIIA!" precursor was not observed
for the N37E mutant (lanes 13–16). In turn, TLP knock-
down resulted in destabilization of the TFIIA!" precursor
(Figure 3B). To demonstrate the inhibitory effect of TLP
on nascent TFIIA protein, we examined the processing ef!-
ciency of TFIIA!" by using exogenously expressed TFIIA.
The exogenous TFIIA!" precursor was processed into each
subunit like the endogenous one (Figure 3C, lane 2). As ex-
pected, TLP, but not N37E, decreased the processing rate
for exogenous TFIIA!" (Figure 3C). Moreover, the pro-
tein level of DGAA mutant TFIIA, which is not processed
by Taspase1, was not affected by TLP overexpression (Fig-
ure 3D). The amount of TFIIA transcript was not affected
by TLP (Figure 3E). These results suggest that processing
of TFIIA!" precursor is inhibited by TLP.
We showed that the TFIIA!" precursor was not de-
graded by the ubiquitin-proteasome system (Figure 4A).
We further checked whether reduction of the precursor was
due to Taspase1 (Figure 4B). We examined the inhibitory
effect of TLP on in vivo processing of the TFIIA!" pre-
cursor using puri!ed recombinant proteins. Although the
precursor of recombinant TFIIA!" was suf!ciently pro-
 at CHIBA DAIGAKU on July 27, 2015
http://nar.oxfordjournals.org/
Downloaded from 
Nucleic Acids Research, 2015, Vol. 43, No. 13 6291
Figure 3. Inhibitory effect of TLP on the processing of TFIIA!". TFIIA!" protein was determined by Western blotting. (A) Effect of overexpressed
TLP on intracellular TFIIA!" protein. TLP- and N37E-introduced HCT116 cells were treated with CHX for the indicated time, and the amount of
endogenous TFIIA protein was determined. (B) Effect of TLP knockdown on TFIIA!" precursor. The amount of endogenous TFIIA!" precursor in
TLP-knocked-down HeLa cells was assayed as described above. (C) Effect of TLP on TFIIA!" processing. HeLa cells were transfected with expression
plasmids for FH-TLP and FH-N37E together with FH-TFIIA!", and the TFIIA!" precursor and generating ! subunit were detected. (D) Effect of TLP
on the uncleavable DGAA mutant. HeLa cells were transfected with expression plasmids of FH-TFIIA and FH-DGAA mutant together with TLP, and
the amount of the FH-TFIIA!" precursor was determined. FH-MyoD introduced into cells was used as an electrophoresis loading standard. (E) RT-PCR
for detection of TFIIA-L transcripts. TLP-overexpressed HCT116 cells were assayed for TFIIA-L transcripts by RT-PCR using speci!c primers.
cessed into ! and " subunits by recombinant Taspase1
(Figure 4C), supplementation of TLP protein clearly pre-
vented the processing of TFIIA!" in a TLP-dose depen-
dent manner, while the !IIA mutant of TLP, which has
no af!nity to TFIIA, did not affect the processing ef-
!ciency (Figure 4D). Taken together, the results showed
that TLP inhibits Taspase1-driven processing of TFIIA!".
Since TFIIA-binding ability-de!cient TLP mutants did not
affect the processing rate of the TFIIA!" precursor, direct
binding of TLP to TFIIA!" was suggested to be critical for
prevention of the processing.
TATA promoter activation by processed TFIIA!"
Since TLP repressed TATA-containing genes and inhibited
processing of the TFIIA!" precursor, we speculated that
TLP negatively regulates TATA genes through inhibiting
TFIIA!" processing. However, it has remained ambiguous
how the processing of the TFIIA!" precursor functions in
potentiation of TATA promoters.
To clarify the signi!cance of TFIIA!" processing for
promoter regulation, we performed an EMSA to exam-
ine the TATA box-association potential of processed and
unprocessed forms of TFIIA!". First, we con!rmed that
puri!ed recombinant TFIIA!" was processed by Tas-
pase1, whereas the DGAA mutant was not affected (Fig-
ure 5A). Although TBP alone did not stably bind to the
TATA box, addition of TFIIA generated a higher protein
(TBP-TFIIA)-DNA complex (Figure 5B). Unprocessed
TFIIA!" and processed TFIIA!" generated two speci!c
complexes. The combination of TBP, TFIIA# and unpro-
cessed TFIIA!" or DGAA mutant generated a faster mi-
grating complex (lower complex) (Figure 5B(a), lanes 3, 5
and 6). On the other hand, processed TFIIA!" generated
a slower migrating complex (upper complex) together with
TBP and TFIIA# (Figure 5B(a), lane 4). Since combina-
tions of TBP and TFIIA!", or TBP and TFIIA# did not
generate stable protein-DNA complex (Figure 5B(b)), both
TFIIA!" and TFIIA# were suggested to be required for
formation of TBP-based protein-DNA complex. A compe-
tition assay revealed that these complexes were speci!c for
the TATA box sequence (Figure 5C). We further performed
a super-shift assay using speci!c antibodies to clarify the
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Figure 4. Inhibition of Taspae1-mediated processing of the TFIIA!" precursor by TLP. (A) Effect of MG132 on TFIIA proteins. HCT116 cells were
treated with MG132 and CHX for the indicated time, and the amount of TFIIA protein was determined. (B) Effect of overexpressed Taspase1 on the
endogenous TFIIA!" precursor. HCT116 cells were transfected with expression plasmids of FH-Taspase1, and the amount of the TFIIA!" precursor
was determined. (C) Taspase1-mediated processing of the TFIIA!" precursor in vitro. Five nanograms of puri!ed recombinant TFIIA!" was mixed with
20 ng of puri!ed recombinant FH-Taspase1 and incubated at 37◦C for 1.5 h, and proteins were detected by Western blotting. Effect of TLP on Taspase1-
mediated processing of the TFIIA!" precursor in vitro. Twelve nanograms of TFIIA!" and 6 ng of TFIIA# were incubated with 50 to 200 ng of TLP or
!IIA mutant protein at 37◦C for 1 h. Fifty nanograms of FH-Taspase1 was then added to the mixture and incubated for 1.5 h.
characteristic of these complexes. It was con!rmed that
both complexes contain TBP because these shifted bands
reacted with a TBP-speci!c antibody (Figure 5D, lanes 2
and 5). However, these shifted bands exhibited different re-
action to a TFIIA-speci!c antibody (Figure 5D, lanes 3 and
6). Because the lower complex did not react to TFIIA anti-
body, it was suggested that TFIIA!" was not included in
the lower complex, whereas processed form of TFIIA!"
was included in the upper complex. These EMSA results
show that the processing step of TFIIA!" is required for
stable association of TFIIA with the TATA box.
We performed ChIP analyses to determine whether the
processing of TFIIA!" is critical for its in vivo association
with TATA promoters. Exogenously expressed TFIIA!"
was processed into the subunits (Figure 6A(a)). Processed
TFIIA proteins were detected at the TATA promoter of
the endogenous GAPDH gene, while the DGAA mutant
was not detected at the promoter (Figure 6A(b)). Analy-
sis of the promoter activation function of TFIIA showed
that unprocessed TFIIA!" is almost inert for the TATA-
containing promoter (Figure 6B). To investigate the mecha-
nism to achieve transcriptional activation by processed and
unprocessed TFIIA!", we examined the interaction of the
TFIIA!" precursor (DGAA) with TFIIA# . Although the
TFIIA!" precursor and processed TFIIA exhibited simi-
lar af!nity to TLP, the TFIIA!" precursor exhibited lower
af!nity to TFIIA# (Figure 6C). The function assay revealed
that TFIIA# is required for TFIIA!"-mediated potenti-
ation of the TATA promoter. A dose-responsive effect of
TFIIA# on TFIIA!"-mediated TATA promoter activation
was observed (Figure 6D). The TFIIA# subunit is thus
thought to be required for potentiation of TATApromoters.
Indeed, the EMSA showed that stable protein-DNA com-
plexes were not generated in the absence of TFIIA# (Figure
5B(b)). Consequently, it was clari!ed that processing of the
TFIIA!" precursor is required for its association with the
TATA box and TFIIA# -dependent potentiation of target
promoters. Therefore, inhibition of TFIIA!" processing by
TLP is responsible for depression of TATA genes.
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Figure 5. EMSA to detect the association of TFIIA with TATA the box. (A) in vitro processing of recombinant TFIIA!" precursor protein. Twenty
nanograms of puri!ed recombinant TFIIA!" and DGAA expressed in E. coli were mixed with 70 ng of puri!ed recombinant FH-Taspase1 and incubated
at 37◦C for 1 h. Proteins were separated by SDS-PAGE and detected by silver staining. (B–D) EMSA of TFIIA and TBP to detect TATA box binding of
the GAPDH promoter. Puri!ed TFIIA!", His-TFIIA# and FH-TBP were used. Panel B: (a) processed TFIIA!" (indicated as Processing +, same with
!" of panel b) and unprocessed TFIIA!" (indicated as Processing -, same with !/" of panel b) were used for EMSA. Processing: puri!ed recombinant
TFIIA!" and DGAA were incubated with FH-Taspase1, and TFIIA proteins were puri!ed. (b) Indicated combinations of puri!ed proteins were used for
EMSA. Panel C: cold probe DNA (WT) and its mutant (mut) were used as competitors in EMSA binding reactions. Sequences of wild-type and mutant
competitors were 5′-CGGTTTCTATAAATTGAGCC and 5′-CGGTTTCCAGTAACTGAGCC, respectively. Panel D: speci!c antibodies against TBP,
TFIIA!" and control IgG were included in the EMSA. !" and !/" indicate unprocessed and processed TFIIA!", respectively.
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Figure 6. In vivo function of mature TFIIA! and TFIIA". (A) Chromatin binding of TFIIA!". Wild-type FH-TFIIA!" (WT) and FH-DGAA (DGAA)
were introduced into HeLa cells. Processing of wild-type TFIIA!" was checked by Western blotting (a). Amounts of chromatin-bound exogenous FH-
TFIIA!" and FH-DGAAwere determined by ChIP usingM2Agarose beads. ChIP enrichment at the TATA box-containingGAPDH promoter (GAPDH
pro) and control DNA region (p21FUR) was determined by qPCR (b). Ctrl indicates control. (B) Activation of TATA promoter. Wild-type FH-TFIIA!"
and FH-DGAA were introduced into HeLa cells together with indicated p21 reporter constructs, and the luciferase activity was determined. (C) Af!nity
of TFIIA!" to its interacting proteins. Exogenously expressed FH-TFIIA!" and FH-DGAA were immunoprecipitated with M2 Agarose beads, and co-
precipitated TLP and TFIIA# were detected. Inp: input. (D) A dose-responsive effect of TFIIA# on TATA promoter activation. Indicated combinations
of TFIIAs were introduced into HCT116 cells together with p21-65/GL4 reporter plasmid, and luciferase activity was determined. For dose-dependent
analysis, 100 ng (+) or 200 ng (++) of TFIIA# expression plasmid was used.
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Prevention of chromatin binding of TBP by TLP
TBP is essential for potentiation of TATA promoters, and
TFIIA supports TBP function through stabilization of the
TBP-DNA association (9). Since TLP repressed TFIIA ac-
tivity, it is speculated that TBP-DNA binding is affected by
TLP. To con!rm this hypothesis, we examined the amount
of chromatin-bound TBP by cell fractionation and ChIP
techniques. As expected, the amount of chromatin-bound
TBP was markedly increased in a TLP-knocked-down con-
dition (Figure 7A). Moreover, ChIP results showed that
chromatin-bound TBP was speci!cally increased in the
core promoter region (Figure 7B). This TLP-knockdown-
dependent increase in TBP-chromatin binding was corre-
lated with the increase in expression levels of TATA genes
(Figure 1A). These results suggest that TLP works as a neg-
ative factor for TBP-driven transcription through inhibiting
TFIIA function.
DISCUSSION
Repression of TATA genes by TLP
Since TLP is one of the TBP-family proteins, the role of
TLP in transcription regulation has been studied (21,22).
The most attractive characteristic of TLP is the highest
af!nity to TFIIA (17,18). In the transcription regulation
of TATA-less promoters, several direct regulatory mecha-
nisms of TLP have been shown over the past decade. We
previously demonstrated that TATA-less promoters includ-
ing cyclinG2, TAp63 and p21 need TLP-TFIIA interaction
for transcription activation (23–25,33,36). Other groups
demonstrated that several TATA-less promoters are also
governed by TLP (e.g. TCT- and DPE-driven promoters
and promoters of the histone gene cluster of Drosophila)
(26,27). On the other hand, the mechanism by which TATA
genes are affected by the TLP-TFIIA interaction in vivo has
remained unclear. In this study, we showed that the TLP-
TFIIA interaction has a negative effect on TATA genes
(Figures 1 and 2). We found a novel mechanism that TLP
inhibits TATA genes expression through preventing TFIIA
maturation (Figures 3 and 4). Since 24%of the core promot-
ers of human genes have a typical TATA box or TATA-like
element (3), TLP may widely affect the expression of TATA
genes as a global regulator.
TLP behaves as an inhibitor of TFIIA processing
Sequence-speci!c cleavage of proteins is critical for reg-
ulation of cellular functions such as cell death, home-
ostasis and cell-cycle progression (37–39). TFIIA!" has
been demonstrated to be subjected to Taspase1-mediated
proteolytic processing for production of mature TFIIA!
and TFIIA" (13). Although the processing of TFIIA!" is
known to be critical in spermatogenesis and head morpho-
genesis (14,40), the regulation mechanism of TFIIA!" pro-
cessing has remained unknown. We found that TLP func-
tions as an inhibitor of TFIIA!" processing (Figures 3 and
4). TLP has a speci!c and critical function for TFIIA!"
through its strong af!nity to TFIIA. Results of this study
suggest that direct binding of TLP to TFIIA!" is required
for inhibition of TFIIA!" processing (Figures 3 and 4D).
Although the amino acid sequence of TBP is 40% similar
to that of TLP (19,28), TBP never inhibits the processing
in vivo (data not shown). Our previous works have further
shown that TLP has one-order higher af!nity to TFIIA
than TBP does (18). The high degree of stability of the
TLP-TFIIA complex ensures the prevention of Tapsase1-
mediated processing of the TFIIA!" precursor. These ob-
servations suggest that TLP is not just a TBP alternative
with inadequate ability but is a unique factor with a func-
tion distinct from that of TBP.
TFIIA!" processing is required for activation of the TATA
promoter
Although the transcription activation function of TFIIA
has been studied in yeast, yeast TFIIA!" (TOA1) does not
undergo proteolytic processing (13). On the other hand,
the signi!cance of Taspase1-mediated TFIIA!" process-
ing in human cells has not been elucidated. Although,
from results of previous in vitro analyses, the Taspase1-
mediated processing has been thought to be essential step
for the TATA promoter activation (9), several studies
demonstrated that the unprocessed TFIIA!" has transcrip-
tional activity (15,16,40). To demonstrate functional differ-
ences between each form of TFIIA clearly, we examined
TFIIA function in conventionally used cultured cells. Fi-
nally, we showed that the processing of TFIIA is required
for activation of TATA genes in human HeLa cells and
HCT116 cells (Figure 6), and the unprocessed TFIIA!" is
inactive in transcription activation, which is explained be-
low. We demonstrated that there are essential functional
differences between processed and unprocessed forms of
TFIIA!". Only processed TFIIA!" is associated with the
TATA box together with TBP and TFIIA# (Figures 5 and
6). Moreover, processed TFIIA!" has transcription acti-
vation function speci!cally for TATA promoters (Figure
6B). TFIIA# is required for holo-TFIIA function (41),
and the present study revealed that TFIIA# is needed for
both the TATA box associating ability and promoter ac-
tivation function of processed TFIIA!" (Figures 5B and
6D). In agreement with the promoter activation ability of
processed TFIIA!", processed TFIIA!" exhibited higher
af!nity to TFIIA# than did its unprocessed form (Figure
6C). This considerable af!nity is presumably needed for
the TATA box-activation function of processed TFIIA!".
Thus, the Taspase1-mediated processing of the TFIIA!"
precursor is required for acquiring both TATA box as-
sociation ability and promoter activation function. Since
processed TFIIA!" can associate with the TATA box in
the presence of TBP and TFIIA# (Figure 5B), processed
TFIIA!" is likely to function as a co-activator of TBP to-
gether with TFIIA# . Since the unprocessed TFIIA!" does
not exhibit such ability, this co-activator function is thought
to be one of the mature TFIIA!"-speci!c identities.
Unprocessed TFIIA!" can facilitate TBP-TATA box bind-
ing but is inactive in transcription activation
TBP alone does not exhibit high af!nity to the TATA box
(3). This is probably because TBP is a sticky protein and
tends to form functionally inactive homo-dimers (42,43).
 at CHIBA DAIGAKU on July 27, 2015
http://nar.oxfordjournals.org/
Downloaded from 
6296 Nucleic Acids Research, 2015, Vol. 43, No. 13
Figure 7. Negative effect of TLP on chromatin binding of TBP. (A) Amounts of chromatin-bound TBP. Chromatin-unbound (Ch-free) and chromatin-
bound fractions (Ch-bound) were prepared from TLP-knocked-down HeLa cells, and the proteins were detected. Tubulin and histone H4 were used as
standard proteins for chromatin-unbound and chromatin-bound fractions, respectively. (B) Amounts of promoter-bound TBP. TLP-knocked-down HeLa
cells were subjected to a ChIP assay using a TBP-speci!c antibody. ChIP enrichment was determined by qPCR. IgG and TBP: IgG- and TBP-speci!c
immnoprecipitates, respectively.
Figure 8. TLP-dependent promoter selection model of TFIIA. TLP inhibits Taspase1-mediated maturation of TFIIA!" and represses TATA gene expres-
sion. TLP forms a complex with both the processed and unprocessed forms of TFIIA!" and potentiates TLP-mediated genes. Consequently, TLP governs
promoter selectivity of TFIIA and regulates gene expression.
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We previously found that TFIIA enhances the dissociation
of TBP dimers (18,44). Unprocessed TFIIA!" does not ex-
hibit a stable TATAbox-association function (Figures 5 and
6), but it facilitated the formation of a stable TBP-TATA
box complex in solution (Figure 5). Other groups also re-
ported that TBP-TATA box binding is stimulated by un-
processed TFIIA!" (8,41). Hence, even the unprocessed
TFIIA!" can dissociate TBP dimers and orientate a TBP
monomer to the TATA box. Because processed TFIIA!"
also facilitated TBP-TATA box association (Figure 5), the
TBP-TATA stabilizing function of TFIIA!" is restored af-
ter processing. So far, TATA box-association of TFIIA has
been assumed to be required for orientation of TBP to a
TATA box. Data obtained in this study, however, suggest
that even the TFIIA!" precursor, which does not exhibit
association ability with the TATA box, basically has TBP-
TATA box stabilization ability, and Taspase1-directed pro-
cessing enables TFIIA to associate with the TATA box for
full potentiation of TATA promoters as mentioned above.
Consequently, we hypothesize that there are two steps for
TFIIA-mediated potentiation of TATApromoters. The !rst
step is orientation of a TBP monomer to TATA box DNA
without association of TFIIA with the TATA box. The sec-
ond step is TATA box-binding of TFIIA itself for activa-
tion of an associating promoter. Moore et al. demonstrated
by in vitro analysis that TLP prevents TBP-TATA box com-
plex formation as the !rst step through competingwith TBP
for TFIIA binding (28). We clearly showed that TLP pre-
vents TBP-TATA box binding in vivo (Figure 7), probably
due to disruption of TBP-TFIIA interaction by TLP. On
the other hand, it might be possible that TLP disrupts TBP-
TATA box binding via other mechanisms such as alterna-
tion of chromatin structure (45). In any cases, the present
study demonstrated clearly that the Taspase1-mediated pro-
cessing is a novel step for TLP to inhibit TATA-containing
genes (Figure 8).
TLP participates in promoter selectivity of TFIIA
We demonstrated that unprocessed TFIIA!" is inactive
in TATA promoter activation. On the other hand, un-
processed TFIIA!" has much more capacity to activate
a subset of TLP-dependent TATA-less promoters (Figure
8). We found that unprocessed TFIIA!" activates the up-
stream promoter of the human p21Cip1 gene (our un-
published data), which is rather dependent on TLP. Actu-
ally, promoter recruitment of unprocessed TFIIA!" has
been reported. Takeda et al. demonstrated that unpro-
cessed TFIIA!" associates with TATA-less promoters of
p16Ink4a and p19Arf genes and enhances expression of
those genes during mouse craniofacial morphogenesis (40).
Thus, the TFIIA!" precursor is likely to activate TBP-
independent and TLP-governed TATA-less promoters. Be-
cause TLP also interacts with TFIIB, another GTF, TLP-
governed promoters can be regulated by a speci!c transcrip-
tion preinitiation complex containing TLP, unprocessed
TFIIA and TFIIB.
We propose a TLP-governed promoter selectionmodel of
TFIIA (Figure 8). TLP inhibits processing of the TFIIA!"
precursor and accumulates the precursor. Although inhibi-
tion of TFIIA!"maturation by TLP results in repression of
TATAgenes, TLP and accumulating unprocessed TFIIA!"
are cooperatively recruited to TATA-less promoters and po-
tentiate a subset of genes.
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